コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 had a prior CABG; and 86 [15%] had had prior percutaneous transluminal coronary angioplasty).
2 tients with TCAD and two patients undergoing percutaneous transluminal coronary angioplasty).
3 m of stent restenosis in patients with prior percutaneous transluminal coronary angioplasty.
4 formations occur as the initial event after percutaneous transluminal coronary angioplasty.
5 with unstable ischemic syndromes undergoing percutaneous transluminal coronary angioplasty.
6 ng vascular remodeling that occurs following percutaneous transluminal coronary angioplasty.
7 ve SPS and those with an FFR <0.75 underwent percutaneous transluminal coronary angioplasty.
8 for coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty.
9 onary artery bypass graft (CABG) surgery and percutaneous transluminal coronary angioplasty.
10 le by coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty.
11 he high rates of restenosis that occur after percutaneous transluminal coronary angioplasty, a widesp
12 patients after myocardial infarction, after percutaneous transluminal coronary angioplasty, after co
13 ear restenosis rate was 49% (64% for balloon percutaneous transluminal coronary angioplasty and 33% f
14 ibute to the development of restenosis after percutaneous transluminal coronary angioplasty and accel
15 ion comparing initial revascularization with percutaneous transluminal coronary angioplasty and coron
16 coronary revascularization procedure (i.e., percutaneous transluminal coronary angioplasty and coron
17 rization, coronary artery bypass surgery, or percutaneous transluminal coronary angioplasty and had n
18 role in the development of restenosis after percutaneous transluminal coronary angioplasty and in th
19 elease of inflammatory mediators occur after percutaneous transluminal coronary angioplasty and may p
20 ients (63%) underwent revascularization with percutaneous transluminal coronary angioplasty and/or co
21 oth coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty are direc
23 d circumflex coronary arteries with standard percutaneous transluminal coronary angioplasty balloon c
24 terization, coronary-artery bypass grafting, percutaneous transluminal coronary angioplasty, carotid
25 nderwent percutaneous instrumentation with a percutaneous transluminal coronary angioplasty catheter
26 Percutaneous transluminal coronary angioplasty catheters
27 te coronary syndrome, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary
28 they had a history of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary
29 ith known coronary artery disease, and after percutaneous transluminal coronary angioplasty, coronary
30 eedom from myocardial infarction, stent-site percutaneous transluminal coronary angioplasty, coronary
31 years for incidence of nonfatal MI, stroke, percutaneous transluminal coronary angioplasty, coronary
32 nonfatal myocardial infarction (MI), stroke, percutaneous transluminal coronary angioplasty, coronary
33 ation of diagnostic coronary angiography and percutaneous transluminal coronary angioplasty; direct h
34 Interventional procedures included percutaneous transluminal coronary angioplasty, directio
35 ative coronary lesions in 209 patients after percutaneous transluminal coronary angioplasty, directio
36 on (coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty) during s
37 to the time of their intervention: group 1 (percutaneous transluminal coronary angioplasty era), gro
38 study was to compare the outcome of primary percutaneous transluminal coronary angioplasty for acute
39 etween 1981 and 1989, 505 patients underwent percutaneous transluminal coronary angioplasty for post-
40 in during balloon occlusion while undergoing percutaneous transluminal coronary angioplasty for singl
41 have changed in elderly patients undergoing percutaneous transluminal coronary angioplasty from the
42 ilatory reserve (CVR) does not improve after percutaneous transluminal coronary angioplasty in > or =
43 th the 904 randomized patients who underwent percutaneous transluminal coronary angioplasty in BARI.
44 establish the safety and efficacy of primary percutaneous transluminal coronary angioplasty in patien
45 stenting with those for balloon angioplasty (percutaneous transluminal coronary angioplasty) in conte
47 al coronary artery occlusion during elective percutaneous transluminal coronary angioplasty is associ
48 ment of coronary athero-occlusive disease by percutaneous transluminal coronary angioplasty is hamper
52 ative coronary and 30 vein grafts) underwent percutaneous transluminal coronary angioplasty, laser ab
53 ents with ISR in native coronaries underwent percutaneous transluminal coronary angioplasty, laser an
54 ith early coronary artery bypass grafting or percutaneous transluminal coronary angioplasty, <60 days
56 otion) was assessed after revascularization (percutaneous transluminal coronary angioplasty, n=20; co
57 86 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty (NHLBI PT
59 e hemostatic profiles of patients undergoing percutaneous transluminal coronary angioplasty or corona
60 en, and rates of cardiac catheterization and percutaneous transluminal coronary angioplasty or corona
61 atients were subjected to revascularization (percutaneous transluminal coronary angioplasty or corona
62 mined 4484 patients who underwent successful percutaneous transluminal coronary angioplasty or direct
63 disease were treated by random assignment to percutaneous transluminal coronary angioplasty or medica
64 infarction, coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, or angio
65 ), unstable angina, cardiac catheterization, percutaneous transluminal coronary angioplasty, or coron
66 larization (coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, or other
67 t outcomes of diabetic coronary angioplasty (percutaneous transluminal coronary angioplasty, or PTCA)
68 edictors of coronary artery bypass graft and percutaneous transluminal coronary angioplasty (p<0.001
69 er nonballoon devices (19.5% vs. 11.5% after percutaneous transluminal coronary angioplasty; p < 0.01
70 red with historical results with multivessel percutaneous transluminal coronary angioplasty, patients
71 , 'Coronary Artery Bypass Grafting' (CABG), 'percutaneous transluminal coronary angioplasty' (PCTA) a
72 h open versus closed coronary arteries after percutaneous transluminal coronary angioplasty performed
73 same-sitting diagnostic catheterization and percutaneous transluminal coronary angioplasty (PTCA) (a
74 This study sought to compare the outcome of percutaneous transluminal coronary angioplasty (PTCA) (n
75 ients treated with a stent in one branch and percutaneous transluminal coronary angioplasty (PTCA) (w
76 complication rates and clinical features of percutaneous transluminal coronary angioplasty (PTCA) af
77 t, compared with early thrombolysis, primary percutaneous transluminal coronary angioplasty (PTCA) af
78 ntation and may be successfully managed with percutaneous transluminal coronary angioplasty (PTCA) al
79 randomization including 1,154 patients with percutaneous transluminal coronary angioplasty (PTCA) al
80 nal Heart, Lung, and Blood Institute (NHLBI) Percutaneous Transluminal Coronary Angioplasty (PTCA) an
82 venous blood samples were obtained from 100 percutaneous transluminal coronary angioplasty (PTCA) an
83 rombus has developed as a complication after percutaneous transluminal coronary angioplasty (PTCA) an
84 ted) coronary artery revascularization using percutaneous transluminal coronary angioplasty (PTCA) an
85 etween angina occurring spontaneously before percutaneous transluminal coronary angioplasty (PTCA) an
86 coronary artery bypass graft surgery (CABG), percutaneous transluminal coronary angioplasty (PTCA) an
87 na (RITA) trial compares initial policies of percutaneous transluminal coronary angioplasty (PTCA) an
88 determine the relative risks and benefits of percutaneous transluminal coronary angioplasty (PTCA) an
89 ned to compare the long-term consequences of percutaneous transluminal coronary angioplasty (PTCA) an
90 ents with and without diabetes after initial percutaneous transluminal coronary angioplasty (PTCA) an
91 er expert panel rated the appropriateness of percutaneous transluminal coronary angioplasty (PTCA) an
93 designed to determine the risk of performing percutaneous transluminal coronary angioplasty (PTCA) at
95 ardial infarction (AMI) at hospitals without percutaneous transluminal coronary angioplasty (PTCA) ca
96 inical outcomes after reperfusion by primary percutaneous transluminal coronary angioplasty (PTCA) co
97 ary Doppler flow velocity in patients during percutaneous transluminal coronary angioplasty (PTCA) fo
98 nary artery bypass graft surgery (CABG) with percutaneous transluminal coronary angioplasty (PTCA) fo
99 ients should receive thrombolytic therapy or percutaneous transluminal coronary angioplasty (PTCA) fo
101 rials comparing directional atherectomy with percutaneous transluminal coronary angioplasty (PTCA) ha
104 ivered locally, on neointima formation after percutaneous transluminal coronary angioplasty (PTCA) in
105 n pump (IABP) counterpulsation after primary percutaneous transluminal coronary angioplasty (PTCA) in
107 compared with thrombolytic therapy, primary percutaneous transluminal coronary angioplasty (PTCA) in
108 fter coronary artery bypass graft (CABG) and percutaneous transluminal coronary angioplasty (PTCA) in
109 of blood to the injured arterial wall after percutaneous transluminal coronary angioplasty (PTCA) in
110 ial (EAST) was designed to determine whether percutaneous transluminal coronary angioplasty (PTCA) is
112 ronary artery bypass graft surgery (CABG) or percutaneous transluminal coronary angioplasty (PTCA) ma
113 posed risk adjustment models for in-hospital percutaneous transluminal coronary angioplasty (PTCA) mo
115 trips to the catheterization laboratory for percutaneous transluminal coronary angioplasty (PTCA) of
117 to compare the impact of primary stenting or percutaneous transluminal coronary angioplasty (PTCA) on
118 We sought to compare outcomes after primary percutaneous transluminal coronary angioplasty (PTCA) or
119 ry disease randomly assigned to treatment by percutaneous transluminal coronary angioplasty (PTCA) or
120 -vessel coronary disease who were undergoing percutaneous transluminal coronary angioplasty (PTCA) or
121 utcomes after initial revascularization with percutaneous transluminal coronary angioplasty (PTCA) or
122 erence to whether the recommendation was for percutaneous transluminal coronary angioplasty (PTCA) or
123 bility for immediate coronary arteriography, percutaneous transluminal coronary angioplasty (PTCA) or
124 l infarction, stroke and death after a first percutaneous transluminal coronary angioplasty (PTCA) pr
126 term outcome of patients with a "stent-like" percutaneous transluminal coronary angioplasty (PTCA) re
127 broaden assessment of the economic impact of percutaneous transluminal coronary angioplasty (PTCA) re
128 n women in the 1985-1986 and 1993-1994 NHLBI Percutaneous Transluminal Coronary Angioplasty (PTCA) re
129 cess rate and clinical outcomes of a primary percutaneous transluminal coronary angioplasty (PTCA) st
131 ive safety and efficacy of laser-facilitated percutaneous transluminal coronary angioplasty (PTCA) ve
132 physician-guided versus random assignment of percutaneous transluminal coronary angioplasty (PTCA) ve
134 70 years old with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA) wi
135 acute myocardial infarction (AMI) undergoing percutaneous transluminal coronary angioplasty (PTCA) wi
136 any trials have been done to compare primary percutaneous transluminal coronary angioplasty (PTCA) wi
137 comparing mechanical reperfusion by primary percutaneous transluminal coronary angioplasty (PTCA) wi
138 ntra-aortic balloon counterpulsation (IABP), percutaneous transluminal coronary angioplasty (PTCA), a
139 cial differences in cardiac catheterization, percutaneous transluminal coronary angioplasty (PTCA), a
140 s for cardiac artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), a
141 : myocardial infarction (MI), cardiac death, percutaneous transluminal coronary angioplasty (PTCA), a
142 ery bypass grafting (CABG), as compared with percutaneous transluminal coronary angioplasty (PTCA), i
143 dard coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), o
144 study evaluated the hypothesis that primary percutaneous transluminal coronary angioplasty (PTCA), w
145 n high rates of ischemic complications after percutaneous transluminal coronary angioplasty (PTCA).
146 ab, ReoPro) is approved for use in high-risk percutaneous transluminal coronary angioplasty (PTCA).
147 f coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA).
148 patients undergoing coronary reperfusion via percutaneous transluminal coronary angioplasty (PTCA).
149 Rotablator atherectomy and after adjunctive percutaneous transluminal coronary angioplasty (PTCA).
150 mechanisms, of QRS changes occurring during percutaneous transluminal coronary angioplasty (PTCA).
151 o improve outcomes among patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
152 ents with unstable angina who are undergoing percutaneous transluminal coronary angioplasty (PTCA).
153 (AMI) either spontaneously or after primary percutaneous transluminal coronary angioplasty (PTCA).
154 preconditioning (PC) exists in humans during percutaneous transluminal coronary angioplasty (PTCA).
155 omy (ROTA), additional stenting (STENT), and percutaneous transluminal coronary angioplasty (PTCA).
156 s a clinically relevant, undesired effect of percutaneous transluminal coronary angioplasty (PTCA).
157 ry bypass graft surgery (CABG) compared with percutaneous transluminal coronary angioplasty (PTCA).
158 e reduce adverse cardiovascular events after percutaneous transluminal coronary angioplasty (PTCA).
159 preconditioning (PC) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
160 h an increased incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA).
161 y artery bypass grafting (CABG) but not with percutaneous transluminal coronary angioplasty (PTCA).
162 short- and long-term clinical outcomes after percutaneous transluminal coronary angioplasty (PTCA).
163 s to be a high risk morphological subset for percutaneous transluminal coronary angioplasty (PTCA).
164 mal saline; 10 minutes later, they underwent percutaneous transluminal coronary angioplasty (PTCA; th
165 oronary events (coronary death, nonfatal MI, percutaneous transluminal coronary angioplasty [PTCA] or
166 n (coronary artery bypass grafting [CABG] or percutaneous transluminal coronary angioplasty [PTCA]) a
167 followed by low-pressure balloon dilatation (percutaneous transluminal coronary angioplasty [PTCA]) f
168 ality than conventional balloon angioplasty (percutaneous transluminal coronary angioplasty [PTCA]).
169 ed clinical results for balloon angioplasty (percutaneous transluminal coronary angioplasty, PTCA) in
170 pair after mechanical arterial injury (i.e., percutaneous transluminal coronary angioplasty, PTCA) is
172 ital, myocardial infarction, cardiac arrest, percutaneous transluminal coronary angioplasty, repeat C
173 Surgical and percutaneous transluminal coronary angioplasty revascula
175 gies--stand-alone thrombolysis, conventional percutaneous transluminal coronary angioplasty, stenting
176 t-related artery were more likely to undergo percutaneous transluminal coronary angioplasty than othe
179 saline; on the following day, they underwent percutaneous transluminal coronary angioplasty (three 2-
180 Ischemic Complications (EPIC), Evaluation of Percutaneous Transluminal Coronary Angioplasty to Improv
181 precluded coronary-artery bypass surgery or percutaneous transluminal coronary angioplasty, transmyo
182 several clinical scenarios, including after percutaneous transluminal coronary angioplasty, unstable
183 easing age differed in patients treated with percutaneous transluminal coronary angioplasty versus th
184 A prospective study of patients undergoing percutaneous transluminal coronary angioplasty was condu
185 h lab) arrival, technical results when PTCA (percutaneous transluminal coronary angioplasty) was perf
186 zation, coronary-artery bypass grafting, and percutaneous transluminal coronary angioplasty were high
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。